Starting HIV treatment early, before immune damage occurs, brings real clinical benefits. But taking antiretrovirals is a daily, life-long commitment and people need support to make the right choices, writes Bridget Haire.
An international study led by UNSW’s Kirby Institute has shown immediate treatment for people who are HIV positive can halve their risk of HIV-related serious disease or death.
The Kirby Insitute at UNSW has launched a feasibility study to examine whether HIV negative people can take combination drug therapy to reduce their risk of acquiring the virus.
A new range of condoms coated with an antimicrobial chemical are unlikely to offer any more protection from STIs than your average condom, writes Bridgit Haire.
Annual HIV funding from developed to developing countries is about $US18 billion, however this is still about $US5 billion a year short of what’s required to sustain the gains of the last decade, writes William Bowtell.
Two men treated at St Vincent’s Hospital in partnership with UNSW's Kirby Institute have undetectable levels of HIV more than three years after their bone marrow transplants, the first successful cases of the HIV virus being cleared in Australia.
Australia has long been seen as a world leader in HIV prevention, treatment and care, yet our academic sector has been underutilised when it comes to the delivery of international health aid, write David Cooper and John Kaldor.
Unlike plagues of the past, which have often been equalisers, indiscriminately killing nobility and working class, young and old, this modern plague kills very differently, write Michael Kirby and Mark Dybul.
The number of new HIV diagnoses in Australia remains the highest seen for 20 years, according to the Annual HIV Surveillance report released today at UNSW’s Kirby Institute Annual Symposium.
